Results 21 to 30 of about 31,000 (231)
Journal of International Medical Research, 2022 A 33-year-old Chinese woman with a history of immune thrombocytopenic purpura presented with heavy menstrual bleeding. She was found to have thrombocytopenia, plasma ADAMTS13 activity of 0%, and positivity for the plasma ADAMTS13 inhibitor.
Hangping Ge +7 more
doaj +1 more source
Frontiers in Immunology, 2022 For patients with autoimmune diseases, vaccination is controversial. The use of vaccination in patients with autoimmune diseases is controversial. There are many reports of secondary thrombotic thrombocytopenic purpura cases after various vaccinations ...
Yanming Cui, Jianbo Wei, Xiang Peng
doaj +1 more source
Renal cell carcinoma associated with idiopathic thrombocytopenic purpura
International Journal of Immunopathology and Pharmacology, 2020 We presented the clinical data of one patient with renal cell carcinoma associated with idiopathic thrombocytopenic purpura in this case report. We reported a 56-year-old man who presented with petechiae and ecchymoses.
Xi Xie +5 more
doaj +1 more source
Immune thrombocytopenic purpura [PDF]
Journal of Community Hospital Internal Medicine Perspectives, 2019 Immune thrombocytopenic purpura (ITP) is a bleeding disorder characterized by isolated thrombocytopenia (platelet count
Abir Zainal, Amr Salama, Richard Alweis
openaire +3 more sources
Thrombocytopenic purpura as only manifestation of brucellosis in a child
The Turkish Journal of Pediatrics, 2004 Thrombocytopenic purpura associated with brucellosis has been rarely reported in the world literature. Thrombocytopenic purpura is generally part of the array of manifestations of brucellosis such as fever, arthritis, malaise and ...
Mehmet Yalaz +2 more
doaj +1 more source
Thrombotic thrombocytopenic purpura [PDF]
The Journal of the American Osteopathic Association, 1989 Once formerly thought to be a rare disorder, thrombotic thrombocytopenic purpura (TTP) is becoming increasingly recognized. It is characterized by a pentad of clinical findings, including microangiopathic hemolytic anemia, thrombocytopenic purpura, neurologic and renal abnormalities, and fever.
openaire +2 more sources
Balkan Medical Journal, 2018 Background: Thrombotic thrombocytopenic purpura is a potentially life-threatening condition. Although the introduction of therapeutic plasma exchange has reduced mortality rates from over 90% to 10%-20%, approximately 40% of patients relapse, and ...
Seniz Öngören +9 more
doaj +1 more source
Thrombotic thrombocytopenic purpura [PDF]
memo - Magazine of European Medical Oncology, 2018 Thrombotic thrombocytopenic purpura (TTP) is a clearly defined entity of the thrombotic microangiopathies (TMA), a heterogeneous group of disorders characterized by microangiopathic hemolytic anemia with red cell fragmentation, thrombocytopenia and organ dysfunction due to disturbed microcirculation.
openaire +2 more sources
Advances in ITP - therapy and quality of life - a patient survey. [PDF]
, 2011 Current guidelines recommend glucocorticoids and splenectomy as standard 1(st) and 2(nd) line treatments for chronic immune thrombocytopenia (ITP). We sought to find out how German ITP-patients are treated with respect to these guidelines.
Axel C Matzdorff +12 more
core +1 more source
Haematologica, 2016 Acquired thrombotic thrombocytopenic purpura is primarily caused by the deficiency of plasma ADAMTS13 activity resulting from autoantibodies against ADAMTS13.
Wenjing Cao +7 more
doaj +1 more source